Upcoming Events.
ASCO 2023 Annual Meeting
McCormick Place, Chicago, IL, USA and Online
2023 BIO International Convention
Boston, MA, USA
Past Events.
BIONNALE 2023
Berlin, Germany
JMP Securities Life Sciences Conference
New York, NY, USA
ESMO Breast Cancer 2023
Berlin, Germany
KOL Event hosted by Ladenburg Thalmann & Co, Inc.
Deep Dive into Efti Development in NSCLC and HNSCC Landscapes discussion led by Ahu Demir, Ph.D., and featuring Martin Forster, M.D., Ph.D., of the University College London Cancer Institute and UCL Hospital NHS Foundation, and Wade T. Iams, M.D., MSCI, Assistant Professor of Medicine, Vanderbilt-Ingram Cancer Center Division of Hematology/Oncology.
European Lung Cancer Congress 2023
Copenhagen, Denmark
BIO-EUROPE SPRING
Basel, Switzerland
ShareCafe Webinar
Marc Voigt, CEO of Immutep will participate in the upcoming virtual event and will deliver a presentation.
Speaking time of Marc Voigt: 12:30 pm AEDT on Friday, 17 February 2023
J.P. Morgan 41st Annual Healthcare Conference
Marc Voigt, CEO and Deanne Miller, COO will be attending and hosting meetings at the 41st Annual J.P. Morgan Healthcare Conference taking place January 9-12, 2023 at the Westin St. Francis in San Francisco, CA.
The JMP Securities Hematology and Oncology Summit
Marc Voigt, CEO of Immutep will participate in the event virtually and will deliver a corporate presentation.
Speaking time of Marc Voigt: 11:20 AM ET on Wednesday, 7 December 2022
Annual General Meeting 2022
Immutep Annual General Meeting 2022 will be taking place at Offices of Piper Alderman, Governor Macquarie Tower, 1 Farrer Place, Sydney, NSW on Wednesday, 23 November 2022, 11.00 am (AEDT)
13th Annual Jefferies London Healthcare Conference
Marc Voigt, CEO of Immutep will participate in the upcoming in-person conference
Speaking time of Marc Voigt: 1:30pm - 2.00pm (UTC) on Thursday, 17 November 2022
A replay of the webcast is available here
For questions, please email londonhealthcareconf@jefferies.com
SITC - 37th Annual Meeting & Pre-Conference Programs 2022
The company will participate in the upcoming in-person conference.
Venue: Boston, MA
Bell Potter Healthcare Conference 2022
Marc Voigt, CEO and Deanne Miller, COO of Immutep will participate in the upcoming virtual conference and will deliver a presentation.
Speaking time of Marc Voigt: 10:00am - 10:30am (AEDT) on Wednesday, 9 November 2022
Ladenburg Thalmann's 2022 Healthcare Conference
Marc Voigt, CEO and Deanne Miller, COO of Immutep will participate in the upcoming conference to present a corporate overview
Cantor Oncology, Hematology & HemeOnc Conference
Marc Voigt, CEO and Deanne Miller, COO will participate in the in-person conference
Non-Small Cell Lung Cancer (NSCLC) Drug Development Summit
Immutep will participate in the 2nd Non-Small Cell Lung Cancer Drug Development Summit
Frédéric Triebel, CSO & CMO of Immutep speaks on the subject:
A Soluble LAG-3 Protein (Eftilagimod Alpha) with an Anti-PD-1 Antibody (Pembrolizumab): Results of a Phase II Study in NSCLC
Speaking time of Frederic Triebel: 12.00 EST, Thursday 22nd September 2022
CLSA 29th Annual CITIC CLSA Flagship Investors' Forum
Marc Voigt, CEO and Deanne Miller, COO of Immutep will participate in the virtual Investor' Forum
E&P’s Inaugural Small Caps Health Care Conference
Marc Voigt, CEO of Immutep will participate in the conference virtually and Deanne Miller, COO will participate in person.
Speaking time of Marc Voigt: 15:50 pm – 16:20 pm AEST on Tuesday, 6 September 2022
2022 World Conference on Lung Cancer
Immutep will attend to the 2022 World Conference on Lung Cancer.
Jefferies Global Healthcare Conference
Marc Voigt, CEO of Immutep will participate in the upcoming in-person conference and will be available for one to one investor meetings in New York City on June 8-10, 2022.
Speaking time of Marc Voigt: 8:30 AM ET on 10 June, 2022
ASCO 2022 Annual Meeting
Venue: McCormick Place, Chicago, IL, USA